Endra Life Sciences announced its board of directors has appointed Alexander Tokman as acting CEO to replace Francois Michelon, who stepped down from his role as CEO and as a member of the board of directors to pursue other endeavors. The company also announced the addition to its senior management team of Ziad Rouag as head of regulatory and clinical affairs and Richard Jacroux as CFO.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NDRA:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue